Implication of nanotechnology-based approaches to combat SARS-CoV-2 infection.

Heidari, Mana; Salmanpour, Mohsen; Tamaddon, Ali-Mohammad

Heidari, Mana; Salmanpour, Mohsen; Tamaddon, Ali-Mohammad.

Heidari M; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran.
Salmanpour M; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences; Razi Pharmed-Far'avaran Pharmaceutical Inc., Shiraz, Iran.
Tamaddon AM; Center for Nanotechnology in Drug Delivery, Shiraz University of Medical Sciences, Shiraz, Iran.

Indian J Pharmacol ; 53(1): 78-79, 2021.

Article in English | MEDLINE | ID: covidwho-1225883

Subject(s)

Antiviral Agents/administration & dosage; COVID-19 Drug Treatment; Drug Carriers; Nanoparticles; Nanotechnology; SARS-CoV-2/drug effects; Animals; Antiviral Agents/chemistry; Antiviral Agents/pharmacokinetics; COVID-19/virology; Cell Line; Drug Compounding; Humans; SARS-CoV-2/pathogenicity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Drug Carriers / Nanotechnology / Nanoparticles / SARS-CoV-2 / COVID-19 Drug Treatment Limits: Animals / Humans Language: English Journal: Indian J Pharmacol Year: 2021 Document Type: Article Affiliation country: Ijp.ijp_857_20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google